Yajing Huang
Shumei Wei1- 1Department of Pathology, the Second Affiliated Hospital, Zhejiang University, School of Medicine, Hangzhou, China
- 2Department of Breast Surgery and Oncology, the Second Affiliated Hospital, Zhejiang University, School of Medicine, Hangzhou, China
A Correction on
Knowledge mapping of global trends in DNA damage repair-related breast cancer research: a bibliometric study
By Huang Y, Wei S, Hu K and Xiang X (2025) Front. Oncol. 15:1562539. doi: 10.3389/fonc.2025.1562539
There was a mistake in Figure 9D as published. In the published form of Figure 9D, two drugs somehow were not presented, including Stenoparib (distributed in one clinical trial) and Tuvusertib (distributed in one clinical trial). The corrected presentation of Figure 9D appears below.
Figure 9. (A) Annual distribution of a number of clinical trials. (B) Distribution of phases in clinical trials. (C) Distribution of therapy types in clinical trials. (D) Distribution of DDR-related drugs in clinical trials.
The original version of this article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: DNA damage repair, breast cancer, global trends, bibliometric study, CiteSpace, VOSviewer
Citation: Huang Y, Wei S, Hu K and Xiang X (2025) Correction: Knowledge mapping of global trends in DNA damage repair-related breast cancer research: a bibliometric study. Front. Oncol. 15:1646064. doi: 10.3389/fonc.2025.1646064
Received: 12 June 2025; Accepted: 29 August 2025;
Published: 09 September 2025.
Edited and reviewed by:
Giuseppe Giaccone, Cornell University, United StatesCopyright © 2025 Huang, Wei, Hu and Xiang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yajing Huang, aHlqMDA4N0B6anUuZWR1LmNu